Literature DB >> 6866130

Characterization of a common binding site for basic drugs on human alpha 1-acid glycoprotein (orosomucoid).

W E Müller, A E Stillbauer.   

Abstract

The interaction of chlorpromazine, DL-propranolol, and imipramine with isolated alpha 1-acid glycoprotein is characterized by relatively high association constants and only one binding site per protein molecule. The mutual displacement between the three drugs indicates that all three compounds are bound to the same binding site. Several other basic drugs from different pharmacological and chemical classes also displace chlorpromazine, DL-propranolol, and imipramine with potencies, one would predict from their association constants or from the degree of their plasma binding in humans. It is concluded that displacement phenomena like those observed in this study in vitro are likely to occur also in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6866130     DOI: 10.1007/bf00512392

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  Binding of psychotropic drugs to isolated alpha-acid glycoprotein.

Authors:  M L Kornguth; L G Hutchins; B S Eichelman
Journal:  Biochem Pharmacol       Date:  1981-09-01       Impact factor: 5.858

2.  Steroid-protein interactions. XXI. Metal ion inhibition of association between progesterone and alpha 1-acid glycoprotein.

Authors:  J Kerkay; U Westphal
Journal:  Arch Biochem Biophys       Date:  1969-02       Impact factor: 4.013

3.  [Specific binding of dipyridamol on human serum protein. Isolation, identification and characterization as alpha-1-acidic glycoprotein].

Authors:  Z Kopitar; H Weisenberger
Journal:  Arzneimittelforschung       Date:  1971-06

4.  Plasma protein binding of tricyclic anti-depressants in man.

Authors:  O Borgå; D L Azarnoff; G P Forshell; F Sjöqvist
Journal:  Biochem Pharmacol       Date:  1969-09       Impact factor: 5.858

5.  Steroid-protein interactions. XVII. Influence of solvent environment on interaction between human alpha 1-acid glycoprotein and progesterone.

Authors:  M Ganguly; U Westphal
Journal:  J Biol Chem       Date:  1968-12-10       Impact factor: 5.157

6.  Binding of several phenothiazine neuroleptics to a common binding site of alpha 1-acid glycoprotein, orosomucoid.

Authors:  S El-Gamal; U Wollert; W E Müller
Journal:  J Pharm Sci       Date:  1983-02       Impact factor: 3.534

7.  Increased plasma binding of quinidine after surgery: a preliminary report.

Authors:  D Fremstad; K Bergerud; J F Haffner; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

8.  Steroid-protein interactions. XXXIV. Chemical modification of alpha1-acid glycoprotein for characterization of the progesterone binding site.

Authors:  T Kute; U Westphal
Journal:  Biochim Biophys Acta       Date:  1976-01-20

9.  Optical studies on the specific interaction of dipyridamole with alpha 1-acid glycoprotein (orosomucoid).

Authors:  S El-Gamel; U Wollert; W E Müller
Journal:  J Pharm Pharmacol       Date:  1982-03       Impact factor: 3.765

10.  Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma.

Authors:  M K Romach; K M Piafsky; J G Abel; V Khouw; E M Sellers
Journal:  Clin Pharmacol Ther       Date:  1981-02       Impact factor: 6.875

View more
  21 in total

1.  Influence of menstrual cycle phase on serum concentrations of alpha 1-acid glycoprotein.

Authors:  R C Parish; C Spivey
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

2.  Selectivity in the binding of psychotropic drugs to the variants of alpha-1 acid glycoprotein.

Authors:  C B Eap; C Cuendet; P Baumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

3.  Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.

Authors:  G Sager; R Jaeger; C Little
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

4.  Protein binding of the analgesics alfentanil and sufentanil in maternal and neonatal plasma.

Authors:  W Meuldermans; R Woestenborghs; H Noorduin; F Camu; A van Steenberge; J Heykants
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  The plasma protein binding of basic drugs.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

6.  Bioavailability of disopyramide in normal volunteers using unbound concentration.

Authors:  J Braun; F Sörgel; W P Gluth; S Oie
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Interaction of mixed micelles formed from glycocholic acid and lecithin with the protein binding of various drugs.

Authors:  T W Guentert; S Oie; L Paalzow; B M Frey; R Brandt; L J Aarons; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

8.  Kinetics of ajmaline disposition and pharmacologic response in beagle dogs.

Authors:  M Yasuhara; Y Hashimoto; K Okumura; R Hori; T Sakurai; C Kawai
Journal:  J Pharmacokinet Biopharm       Date:  1987-02

9.  Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.

Authors:  R Zini; D Morin; C Salvadori; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

Review 10.  Characterization of drug-protein interactions in blood using high-performance affinity chromatography.

Authors:  David S Hage; Abby Jackson; Matthew R Sobansky; John E Schiel; Michelle J Yoo; K S Joseph
Journal:  J Sep Sci       Date:  2009-03       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.